Results 61 to 70 of about 1,363 (148)
Utility of clot waveform analysis in Russell's viper bite victims with hematotoxicity
Introduction: In Russell's viper bites, due to the lack of a better alternative, whole blood clotting test (WBCT) remains the standard test even though its reliability and sensitivity has been shown to be low. Activated partial thromboplastin time (aPTT)-
Siju V Abraham +6 more
doaj +1 more source
ABSTRACT Severe autoimmune thrombocytopenia (ATP) in systemic lupus erythematosus (SLE) patients can be life‐threatening when refractory to standard treatments. Low‐dose splenic irradiation (LDSI) can provide temporary platelet recovery before definitive splenectomy.
Ryosuke Hanaoka
wiley +1 more source
ABSTRACT Thrombocytopenia (TCP) is a well‐known contraindication for thrombolytic therapy due to the associated risk of bleeding. This report discusses a 34‐year‐old woman presented with massive pulmonary embolism (PE) and severe TCP. She was treated with systemic thrombolysis (ST), and fortunately, a good therapeutic response was achieved without ...
Arman Ahmadzadeh +5 more
wiley +1 more source
Objective Antiphospholipid antibody (aPL) syndrome (APS) classification requires a thrombotic event and detection of lupus anticoagulant (LAC), anticardiolipin antibodies (aCL), or anti–β2‐glycoprotein I (anti‐β2GPI) antibodies on two occasions ≥12 weeks apart. Here, we investigated the utility of anti–phosphatidylserine/prothrombin complex (anti‐PS/PT)
Christina Donath +4 more
wiley +1 more source
ABSTRACT Antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL), macro‐ and micro‐vascular thromboembolic complications. Lupus anticoagulant‐hypoprothrombinemia (LAHPS) may confound the diagnosis and management of bleeding. Catastrophic APS has a category 1 indication for therapeutic plasma exchange (TPE).
Joshua Nicholas +4 more
wiley +1 more source
Understanding Suitable Habitats and Anthropogenic Mortality Risks for King Cobras in Nepal
The king cobra (Ophiophagus hannah), a vulnerable species, faces significant habitat loss and mortality risks in Nepal. Using ensemble modeling with 553 occurrence records, this study identified 23,702.62 km2 of suitable habitat, projecting up to 22% habitat loss by 2050 under SSP2‐4.5 climate scenarios.
Rishi Baral +11 more
wiley +1 more source
Snake antivenom is a specific antidote to the venom action, neutralizing the circulating venom. However, it fails to neutralize the venom fixed to target organs such as platelets, renal tubules, etc. Russell's viper venom initiates rapid coagulation in a
H. S. Bawaskar
doaj +1 more source
Reading and relating with Frieda Fromm‐Reichmann and Joanne Greenberg
Critical Quarterly, EarlyView.
Joshua Pugh
wiley +1 more source
Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific
ABSTRACT Introduction Activated protein C resistance (APCR) represents a risk factor for thrombosis and is usually due to factor V Leiden (FVL). Clinicians may order either test (i.e., APCR or FVL) to help assess ‘thrombophilia’ in patients who present with thrombosis. APCR testing is usually achieved using clot‐based assays, whereas FVL is assessed by
Emmanuel J. Favaloro +8 more
wiley +1 more source
One Bite, Two Severe Envenomations Despite Antivenom Therapy: A Case Report
ABSTRACT This case report describes a 12‐year‐old child who was bitten by a cobra and developed two distinct systemic neurotoxic episodes, 19 h apart, along with severe local envenoming, despite receiving appropriate treatment with antivenom and making a full recovery.
Ravi Shukla +4 more
wiley +1 more source

